Neglia J P, Glaze D G, Zion T E
Pediatrics. 1984 Jun;73(6):841-4.
Three patients are reported who, following the initiation of carbamazepine therapy for seizure control, either experienced the onset of Tourette's syndrome or a worsening of their tics and vocalizations. Blood levels of carbamazepine were within the therapeutic range, and no patient showed clinical signs of intoxication. Tics and vocalizations did not resolve following discontinuation of carbamazepine therapy. Carbamazepine may trigger the onset of Tourette's syndrome in susceptible patients.
报告了3例患者,在开始使用卡马西平控制癫痫发作后,要么出现了 Tourette 综合征,要么其抽搐和发声症状加重。卡马西平的血药浓度在治疗范围内,且没有患者表现出中毒的临床体征。停用卡马西平治疗后,抽搐和发声症状并未缓解。卡马西平可能会在易感患者中引发 Tourette 综合征。